Skip to main content
. 2021 May 6;12:670958. doi: 10.3389/fneur.2021.670958

Figure 3.

Figure 3

Summary of the therapies used and their effects on cognition after 2 years of treatment for the cases with 0–50% SWI at the last follow up. LEV, levetiracetam; VPA, sodium valproate.